NCT02188368 2023-11-03Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma PatientsOncotherapeuticsPhase 2 Terminated45 enrolled
NCT03104270 2022-03-31Combination Study for High Risk Multiple Myeloma PatientsOncotherapeuticsPhase 2 Terminated13 enrolled
NCT00459641 2012-07-17Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone CystsKuros Biosurgery AGPhase 2 Withdrawn